During the past decade, Cape Coral Eye Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cape Coral Eye Center" are "Cataract" (3 trials), "Cataract Extraction" (1 trials), "Cataracts" (1 trials), "Non Arteritic Anterior Ischemic Optic Neuropathy" (1 trials) and "Presbyopia" (1 trials). Many other conditions were trialed in "Cape Coral Eye Center" in a lesser frequency.

Most popular intervention types in "Cape Coral Eye Center" are "Device" (5 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "2 HEMA Hydrophilic Acrylic Intraocular Lens" (1 trials), "Control monofocal intraocular lens" (1 trials), "Healon5 OVD" (1 trials), "Investigational Healon5 OVD" (1 trials) and "QPI-1007 Injection - 1.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cape Coral Eye Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cape Coral Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cape Coral Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cape Coral Eye Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".